Article at Genomeweb: âStratipath Seeks to Ramp up Adoption of AI-Based Breast Cancer Testâ
17 October 2024
Johan Hartman is a guest at the Johnson & Johnson
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Being a leader in the field of AI-based precision diagnostics, Stratipath is constantly moving forward and evolving to provide new tools and strategies for improving patient outcomes. Keep track of developments in our news feeds, or follow us on LinkedIn or Twitter.
Johan Hartman is a guest at the Johnson & Johnson
Advances in breast cancer research are providing entirely new opportunities
Johan Hartman is a guest at the Johnson & Johnson
Stratipath is thrilled to announce a collaboration with Roche, the
In collaboration with iBreastBook, Johan Hartman, co-founder of Stratipath, participated
Stratipath is thrilled to announce a collaboration with Roche, the
Stratipath is excited to announce the publication of a new
Stratipath Breast, is now officially registered with the Medicines and
Johan Hartman is a guest at the Johnson & Johnson
Advances in breast cancer research are providing entirely new opportunities
Johan Hartman is a guest at the Johnson & Johnson